ANVS · Annovis Bio, Inc. · Webcasts, Transcripts & Audio
$1.17
-0.05 (-3.72%)
At close · Oct 12
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management has concluded that substantial doubt exists about the Company's ability to continue as a going concern. Management's plans to mitigate this risk include raising additional capital through equity financings, debt, or other potential alternatives. Management's plans may also include the deferral of certain operating expenses unless and until additional capital is received. However, there can be no assurance that the Company will be successful in raising additional capital or that such capital, if available, will be on terms that are acceptable to the Company, or that the Company will be successful in deferring certain operating expenses. As such, Management has concluded that such plans do not alleviate the aforementioned substantial doubt.”View the 10-Q filed Aug 14, 2026
Market Cap
$49.42M
Shares
42.61M
Volume · Oct 12
197.68K
Avg daily vol (3M)
880.06K
Annovis Bio, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Annovis Bio, Inc. (ANVS), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Earnings call
FY25 · Q2
2025-08-12
Annovis Bio, Inc. (ANVS) Q2 2025 Earnings Call
Diluted EPS
$-0.32
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-21
Annovis Bio, Inc. (ANVS) Q4 2024 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Showing 1–2 of 2 webcasts